Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.00
+0.07 (0.70%)
At close: Mar 19, 2026, 4:00 PM EDT
10.00
0.00 (0.00%)
After-hours: Mar 19, 2026, 4:02 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.79 billion as of March 19, 2026. Its market cap has increased by 231.66% in one year.
Market Cap
1.79B
Enterprise Value
1.26B
1-Year Change
231.66%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $1.79B, a decrease of -40.90%. That is a compound annual growth rate of -8.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.77B | 21.04% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 1.91B |
| Ocular Therapeutix | 1.89B |
| Mesoblast | 1.89B |
| AnaptysBio | 1.86B |
| Definium Therapeutics | 1.82B |
| Recursion Pharmaceuticals | 1.81B |
| Sarepta Therapeutics | 1.78B |
| Zymeworks | 1.76B |